Image

    Comparative Study of Topical Sildenafil 2% and Topical Minoxidil 5% for Male Androgenic Alopecia Treatment

    Mohammed Kotb Ibraheem, Mohammed Amer, Heidi M. Mansour, Yassir Hagag Mohammed Abd El Ati
    Studysummary This study found that topical minoxidil 5% remains the most common treatment for androgenic alopecia due to its high tolerability and patient satisfaction, but topical sildenafil 2% shows promise as an alternative, especially with positive hair thickness outcomes in certain areas.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on aimj.journals.ekb.eg →
    Discuss this study in the Community →

    Related research 2

    1. Contact Dermatitis Caused by Topical Minoxidil: Allergy or Just Irritation Acta Dermato Venereologica · 2025
    2. Minoxidil Sulfotransferase Enzymatical Activity in Plants: A Novel Paradigm in Increasing Minoxidil Response in Androgenetic Alopecia Journal of Cosmetic Dermatology · 2023